Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 9CNS 4Thoracic 1Sarcoma 1NET 1Head & Neck 1Dermatologic 1

Conditions

Neuroendocrine Tumors 28Neoplasms 4Melanoma 4Carcinoma, Neuroendocrine 4Sarcoma 3Pheochromocytoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Liver Neoplasms 3Gastro-enteropancreatic neuroendocrine tumor 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Carcinoid Tumor 3Breast Neoplasms 3Thyroid Neoplasms 2Thymus Neoplasms 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Paraganglioma 2Neoplasms by Site 2Neoplasms by Histologic Type 2Neoplasm Metastasis 2Multiple Myeloma 2Meningioma 2Lung Neoplasms 2Insulinoma 2Head and Neck Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pituitary Neoplasms × NET × 30 days × Clear all
NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

British Columbia Cancer Agency

Active not recruiting
800 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡